Britannia Pharmaceuticals

Part of Nidda German Topco

CompanyUnited KingdomFounded 1981

Britannia Pharmaceuticals develops one asset, in human trials (Lecigon in advanced Parkinson disease). Mostly small molecule acting on Ddc and COMT; based in the United Kingdom, founded in 1981.

1
Asset
Furthest stage: Human trials; 0
Trials: 0
Signals

Pipeline

1

Lecigon
Continuous intestinal delivery of levodopa, carbidopa, and entacapone to manage motor fluctuations.
Human trials, Small molecule, Ddc, COMT, advanced Parkinson disease

Full company profiles: pipeline, trials, funding and people.

In the full profile

Evidence behind the mechanisms2
Similar companies2